PHARMACOKINETICS AND PHARMACODYNAMICS OF LONG-TERM CONTINUOUS-INFUSION DOXORUBICIN

被引：95
作者：
ACKLAND, SP
RATAIN, MJ
VOGELZANG, NJ
CHOI, KE
RUANE, M
SINKULE, JA
机构：
[1] UNIV CHICAGO,PRITZKER SCH MED,DEPT MED,LYNN SAGE CLIN PHARMACOL LAB CANC RES,CHICAGO,IL 60637
[2] UNIV CHICAGO,PRITZKER SCH MED,COMM CLIN PHARMACOL,CHICAGO,IL 60637
[3] UNIV CHICAGO,MICHAEL REESE HOSP & MED CTR,CHICAGO,IL 60616
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1989年 / 45卷 / 04期
关键词：
D O I：
10.1038/clpt.1989.39
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：340 / 347
页数：8
相关论文
共 28 条
[1]   QUANTITATION OF DAUNORUBICIN AND ITS METABOLITES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J].
AKPOFURE, C ;
RILEY, CA ;
SINKULE, JA ;
EVANS, WE .
JOURNAL OF CHROMATOGRAPHY, 1982, 232 (02) :377-383
[2]  
BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO
[3]  
2-M
[4]  
BENJAMIN RS, 1977, CANCER RES, V37, P1416
[5]  
BENNETT CL, 1987, CANCER RES, V47, P1952
[6]  
BRENNER DE, 1984, CANCER, V53, P1042, DOI 10.1002/1097-0142(19840301)53:5<1042::AID-CNCR2820530505>3.0.CO
[7]  
2-B
[8]  
CHLEBOWSKI RT, 1980, CANCER TREAT REP, V64, P47
[9]  
DAVIS HL, 1979, CANCER TREAT REP, V63, P809
[10]  
EGORIN MJ, 1986, CANCER RES, V46, P1513
123